Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02202590 · ClinicalTrials.gov registry record · NA
Using Spectrally Encoded Confocal Microscopy (SECM) to Image the Esophagus
A NA study of Eosinophilic Esophagitis, sponsored by Massachusetts General Hospital.
- Active
- Registry status
- NA
- Development phase
- 96
- Enrollment target
- 1
- Study location
NCT02202590: Active NA study of Eosinophilic Esophagitis, sponsored by Massachusetts General Hospital.
NCT02202590 is a NA study of Eosinophilic Esophagitis that is active but no longer recruiting, run by Massachusetts General Hospital. The registered enrollment target is 96 participants, below the 862-participant average among 44 other Eosinophilic Esophagitis trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02202590, a NA study of Eosinophilic Esophagitis, is active but no longer recruiting, sponsored by Massachusetts General Hospital.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 96 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study is to test the feasibility and the tolerability of a tethered spectrally encoded confocal microscopy (SECM) capsule and to use it to image the esophagus.
Primary Outcome
An investigator will qualitatively assess the the Feasibility of SECM Capsule and Imaging in EoE participant versus Healthy Controls. He will assess the quality of the recorded images and movies obtained with each exam after the imaging is completed. The images obtained by the SECM Capsule will be compared to the images obtained by clinical endoscopy if available.
Conditions Studied
Interventions
- DEVICE SECM Capsule
Study Locations (1)
Massachusetts
- Massachusetts General hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 96 participants |
| Start Date | 2013-10 |
| Est. Completion | 2028-12 |
| Phase | NA |
What the registry record for NCT02202590 still lists
NCT02202590 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 96 participants, a relatively small participant target, below the 862-participant average among 44 other Eosinophilic Esophagitis trials with a reported enrollment target (89% lower).
The record links to 1 condition, with Eosinophilic Esophagitis appearing as the primary indexed condition, and to 1 intervention - of which SECM Capsule is the first listed.
NCT02202590 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT02202590 about?
NCT02202590 is a clinical study titled "Using Spectrally Encoded Confocal Microscopy (SECM) to Image the Esophagus". The goal of this study is to test the feasibility and the tolerability of a tethered spectrally encoded confocal microscopy (SECM) capsule and to use it to image the esophagus.
What is the current status of trial NCT02202590?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 96 participants. The study started on 2013-10. Estimated completion is 2028-12.
What conditions does trial NCT02202590 study?
This clinical trial studies the following conditions: Eosinophilic Esophagitis.
What interventions are being tested in trial NCT02202590?
The interventions under investigation include: SECM Capsule (DEVICE).
Who is sponsoring clinical trial NCT02202590?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02202590 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Eosinophilic Esophagitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02202590's enrollment target sits among peer trials
96 20th of 44 higher than 25 of 44 other Eosinophilic Esophagitis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Eosinophilic Esophagitis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Patient-Centered Decision Support for Eosinophilic Esophagitis
RECRUITING · NA
-
The Esophageal String Test as a Diagnostic Screening Tool for Eosinophilic Esophagitis Among Africans With Dysphagia in Mali and the United States
RECRUITING · NA
-
The Immune Directed Individualized Elimination Therapy (iDIET) Study
ACTIVE NOT RECRUITING · NA
-
Cytosponge and Dietary Therapy in EoE
COMPLETED · NA
-
Use of Esophageal String Test to Understand Symptoms, Inflammation, and Function in Eosinophilic Esophagitis
COMPLETED · NA
-
A Food Additive Removal Diet for Pediatric Eosinophilic Esophagitis
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03401762 · 96 participants · NA
Wearable MCI to Reduce Muscle Co-activation in Acute and Chronic Stroke
- NCT03471260 · 96 participants · Phase 1
Ivosidenib and Venetoclax With or Without Azacitidine in Treating Patients With IDH1 Mutated Hematologic Malignancies
- NCT03549559 · 96 participants · NA
Imaging Histone Deacetylase in the Heart
- NCT03841058 · 96 participants · Phase 2
Abaloparatide vs. Placebo in Post-Menopausal Women and Abaloparatide in Men Receiving Initial Spinal Fusion Surgery
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia